Endpoint NewsMay 22, 2023
“As it awaits key readout, Hepion boosts confidence in NASH drug hopeful via shorter study”
EndpointsSeptember 12, 2022
Hepion Pharma Announces First Dosing in Phase 2b Clinical Trial with HepQuant
Press Releases
September 27, 2023
HepQuant Paticipates in Media Pitch Day
Fitzsimmons Innovation Community hosted its first Media Pitch Day. Check out the summary:
June 13, 2023
HepQuant Announces Additions to the Executive Leadership Team to Drive Commercialization
Kelly R. Pitts, PhD, Chief Operating Officer; Carrie Mulherin, MBA, Chief Commercial Officer; Shailesh Chavan, MD, Chief Medical Officer; Paige Nardi, MBA VP Market Access Denver, CO – June 13, 2023 – HepQuant, LLC, a leader transforming the management of liver diseases, announces key additions to its executive leadership team….
